HYDROXYZINE HYDROCHLORIDE

Post-LOE

hydroxyzine hydrochloride

Novartis

ANDAINJECTIONINJECTABLE

Approved

Aug 1981

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

HYDROXYZINE HYDROCHLORIDE (hydroxyzine hydrochloride) by Novartis is clinical pharmacology hydroxyzine hydrochloride is unrelated chemically to phenothiazine, reserpine, and meprobamate. Approved for anxiety, depression, asthma. First approved in 1981.

Drug data last refreshed 1w ago

Mechanism of Action

CLINICAL PHARMACOLOGY Hydroxyzine hydrochloride is unrelated chemically to phenothiazine, reserpine, and meprobamate. Hydroxyzine has demonstrated its clinical effectiveness in the chemotherapeutic aspect of the total management of neuroses and emotional disturbances manifested by anxiety, tension,…

Indications (3)

anxiety

Worked on HYDROXYZINE HYDROCHLORIDE at Novartis? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.